Marshall University Discovers Fat Cell Pathway as Potential Atherosclerosis Target

Researchers at the Marshall University Joan C. Edwards School of Medicine have discovered a specific cellular signaling pathway in adipocytes that appears to influence the initiation and progression of atherosclerosis. The study, published in a peer‑reviewed journal, identified a cascade of molecular interactions that regulate inflammatory responses and lipid handling within fat cells, both of which are critical factors in plaque formation in arterial walls.

The team used a combination of in‑vitro experiments and animal models to demonstrate that disrupting this pathway reduces the recruitment of immune cells to developing plaques and lowers the accumulation of cholesterol‑laden macrophages. These findings suggest that targeting the newly identified signaling mechanism could complement existing lipid‑lowering therapies and offer a novel approach to preventing or slowing the development of cardiovascular disease.

If further research confirms the pathway’s role in human atherosclerosis, pharmaceutical development could focus on small‑molecule inhibitors or biologics that modulate the pathway’s activity. Such interventions might provide an additional tool for clinicians to reduce cardiovascular risk in patients who remain vulnerable despite current treatment options.